Cargando…
Reducing red blood cell folate testing: a case study in utilisation management
Mandatory enrichment of wheat flour in Canada with folic acid since 1998 has caused folate deficiency to be rare. There were 3019 red blood cell (RBC) folate tests performed during an 18-month period at London Health Sciences Centre (LHSC)/St. Joseph’s Healthcare London (SJHC) without any folate def...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440601/ https://www.ncbi.nlm.nih.gov/pubmed/30997421 http://dx.doi.org/10.1136/bmjoq-2018-000531 |
_version_ | 1783407417875234816 |
---|---|
author | Ismail, Ola Chin-Yee, Ian Gob, Alan Bhayana, Vipin Rutledge, Angela |
author_facet | Ismail, Ola Chin-Yee, Ian Gob, Alan Bhayana, Vipin Rutledge, Angela |
author_sort | Ismail, Ola |
collection | PubMed |
description | Mandatory enrichment of wheat flour in Canada with folic acid since 1998 has caused folate deficiency to be rare. There were 3019 red blood cell (RBC) folate tests performed during an 18-month period at London Health Sciences Centre (LHSC)/St. Joseph’s Healthcare London (SJHC) without any folate deficiency detected. We implemented a quality improvement initiative to reduce RBC folate testing at LHSC/SJHC. We began with a retrospective review of RBC folate tests performed during the previous 18 months. We identified physicians who had ordered more than five tests during this period and sent them an educational email to inform them of our intentions and solicit their input. We then discontinued RBC folate testing in-house and a pop-up window was introduced to the computerised physician order entry system stating that biochemist approval would be needed before samples would be sent out for testing. During the audited 18-month period, the average monthly test volume was 168 (SD 20). The three departments ordering the most RBC folate testing were nephrology (15%), haematology (7%) and oncology (7%). Physician feedback was supportive of the change, and during the 2 months after targeted email correspondence, the average monthly test volume decreased 24% (p<0.01) to 128 (SD 1). On discontinuation of the test in-house and implementation of the pop-up, the average monthly test volume decreased another 74% (p<0.01) to 3 (SD 2). In the 10 months following discontinuation of the test on-site, there were only 39 RBC folate tests performed with no deficiency detected. This initiative significantly reduced unnecessary RBC folate orders. The change in ordering on email contact suggests that physician education was an important factor reducing overutilisation. However, the most significant decrease came from restricting the test so that only orders approved by a biochemist would be performed. |
format | Online Article Text |
id | pubmed-6440601 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-64406012019-04-17 Reducing red blood cell folate testing: a case study in utilisation management Ismail, Ola Chin-Yee, Ian Gob, Alan Bhayana, Vipin Rutledge, Angela BMJ Open Qual BMJ Quality Improvement report Mandatory enrichment of wheat flour in Canada with folic acid since 1998 has caused folate deficiency to be rare. There were 3019 red blood cell (RBC) folate tests performed during an 18-month period at London Health Sciences Centre (LHSC)/St. Joseph’s Healthcare London (SJHC) without any folate deficiency detected. We implemented a quality improvement initiative to reduce RBC folate testing at LHSC/SJHC. We began with a retrospective review of RBC folate tests performed during the previous 18 months. We identified physicians who had ordered more than five tests during this period and sent them an educational email to inform them of our intentions and solicit their input. We then discontinued RBC folate testing in-house and a pop-up window was introduced to the computerised physician order entry system stating that biochemist approval would be needed before samples would be sent out for testing. During the audited 18-month period, the average monthly test volume was 168 (SD 20). The three departments ordering the most RBC folate testing were nephrology (15%), haematology (7%) and oncology (7%). Physician feedback was supportive of the change, and during the 2 months after targeted email correspondence, the average monthly test volume decreased 24% (p<0.01) to 128 (SD 1). On discontinuation of the test in-house and implementation of the pop-up, the average monthly test volume decreased another 74% (p<0.01) to 3 (SD 2). In the 10 months following discontinuation of the test on-site, there were only 39 RBC folate tests performed with no deficiency detected. This initiative significantly reduced unnecessary RBC folate orders. The change in ordering on email contact suggests that physician education was an important factor reducing overutilisation. However, the most significant decrease came from restricting the test so that only orders approved by a biochemist would be performed. BMJ Publishing Group 2019-03-07 /pmc/articles/PMC6440601/ /pubmed/30997421 http://dx.doi.org/10.1136/bmjoq-2018-000531 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | BMJ Quality Improvement report Ismail, Ola Chin-Yee, Ian Gob, Alan Bhayana, Vipin Rutledge, Angela Reducing red blood cell folate testing: a case study in utilisation management |
title | Reducing red blood cell folate testing: a case study in utilisation management |
title_full | Reducing red blood cell folate testing: a case study in utilisation management |
title_fullStr | Reducing red blood cell folate testing: a case study in utilisation management |
title_full_unstemmed | Reducing red blood cell folate testing: a case study in utilisation management |
title_short | Reducing red blood cell folate testing: a case study in utilisation management |
title_sort | reducing red blood cell folate testing: a case study in utilisation management |
topic | BMJ Quality Improvement report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440601/ https://www.ncbi.nlm.nih.gov/pubmed/30997421 http://dx.doi.org/10.1136/bmjoq-2018-000531 |
work_keys_str_mv | AT ismailola reducingredbloodcellfolatetestingacasestudyinutilisationmanagement AT chinyeeian reducingredbloodcellfolatetestingacasestudyinutilisationmanagement AT gobalan reducingredbloodcellfolatetestingacasestudyinutilisationmanagement AT bhayanavipin reducingredbloodcellfolatetestingacasestudyinutilisationmanagement AT rutledgeangela reducingredbloodcellfolatetestingacasestudyinutilisationmanagement |